About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

Kohjin Bio Co.,Ltd.(177A) Summary

177A
TSE Growth
Kohjin Bio Co.,Ltd.
1,684
JPY
-16
(-0.94%)
Apr 4, 11:26 am JST
11.52
USD
Apr 3, 10:26 pm EDT
Result
PTS
outside of trading hours
1,640
Apr 3, 11:31 pm JST
Summary Chart Historical News Financial Result
PER
13.6
PBR
1.57
Yield
0.83%
Margin Trading Ratio
Stock Price
Apr 4, 2025
Opening Apr 4, 9:00 am
1,700 JPY 11.62 USD
Previous Close Apr 3
1,700 JPY 11.54 USD
High Apr 4, 10:23 am
1,735 JPY 11.86 USD
Low Apr 4, 11:08 am
1,654 JPY 11.32 USD
Volume
2,400
Trading Value
4.00M JPY 0.03M USD
VWAP
1694.33 JPY 11.61 USD
Minimum Trading Value
168,400 JPY 1,152 USD
Market Cap
8.61B JPY 0.06B USD
Number of Trades
22
Liquidity & Number of Trades
As of Apr 4, 2025
Liquidity
Slightly High
1-Year Average
606
1-Year High Apr 25, 2024
24,145
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 28, 2025 0 149,600
Mar 21, 2025 0 149,100
Mar 14, 2025 0 152,400
Mar 7, 2025 0 155,400
Feb 28, 2025 0 159,500
Company Profile
Kohjin Bio Co., Ltd. specializes in the development, manufacturing, and sales of cell culture media, as well as contract manufacturing of cell-processed products.
Sector
Chemicals
Kohjin Bio Co., Ltd. primarily focuses on the manufacturing and sales of bacterial culture media, in vitro diagnostic pharmaceuticals, and cell culture media, while also emphasizing regenerative medicine. The company particularly concentrates on developing and selling serum-free media, providing culture media for stem cells and immune cells. Additionally, they manufacture and sell antigen test kits for COVID-19 and influenza. In their cell processing business, Kohjin Bio manufactures specific cell-processed products commissioned by medical institutions and offers regulatory compliance support for regenerative medicine. Working in collaboration with domestic and international group companies, Kohjin Bio provides a wide range of products and services related to microbial testing and regenerative medicine.